Induction and detection of disturbed homeostasis in cardiopulmonary bypass

Perfusion

Volumn 19, Issue 5, 2004, Pages 267-276

  de Vroege, R ^a   te Meerman, F ^b   Eijsman, L ^a   Wildervuur, W R ^a   Wildevuur, Ch R H ^a   van Oeveren, W ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BIOCHEMICAL MARKER; CORTICOSTEROID; CREATINE KINASE; CREATININE; ENDOTHELIN 1; FATTY ACID BINDING PROTEIN; GLUCOSAMINIDASE; HEAT SHOCK PROTEIN; LACTIC ACID; MONOCLONAL ANTIBODY; N ACETYL BETA GLUCOSAMINIDASE; NITRIC OXIDE; PROTEIN S100B; TROPONIN;

ARTICLE; CARDIOPULMONARY BYPASS; HEMODYNAMICS; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; INFLAMMATION; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; MICROCIRCULATION; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SAFETY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE DEGENERATION; TISSUE PERFUSION; VALIDATION PROCESS;

BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HUMANS; INFLAMMATION;

EID: 5544308138     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659104pf757oa     Document Type: Article

References (77)

1. Utley JR, Wachtel C, Caine RB, Spaw EA, Collins JC, Stephens DB. Effects of hypothermia, haemodilution, and pump oxygenation on organ water content, blood flow and oxygen delivery, and renal function. Ann Thorac Surg 1981; 31: 121-33.
2. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
3. Jansen PGM, te Velthuis H, Wildevuur WR et al. Cardiopulmonary bypass with modified gelatin and heparin-coated circuits. Br J Anaesth 1996; 76: 13-19.
4. DeFoe GR, Ross CS, Olmstead EM et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 2001; 71: 769-76.
5. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 2003; 125: 1438-50.
6. Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg 2002; 73: 1912-18.
7. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 2002; 74: 1180-86.
8. Jansen PGM, te Velthuis H, Bulder ER et al. Reduction in prime volume attenuates the hyperdynamic response after cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 544-50.
9. Mitchel BA. Optimal perfusion flow rates for cardiopulmonary bypass. J Extra Corpor Technol 1991; 22: 165-83.
10. Fiddian-Green RG. Gut mucosal ischemia during cardiac surgery. Semin Thorac Cardiovasc Surg 1990; 2: 389-409.
11. Jansen PGM, te Velthuis H, Oudemans-van Straaten HM et al Perfusion related factors of endotoxin release during cardiopulmonary bypass. Eur J Cardiothorac Surg 1994; 8: 125-29.
12. te Velthuis H, Jansen PGM, Oudemans-van Straaten HM, Sturk A, Eijsman L, Wildevuur ChRH. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J Thorac Cardiovasc Surg 1995; 110: 1663-69.
13. Cremer J, Martin M, Redl H et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1714-20.
14. Blinman T, Maggard M. Rational manipulation of oxygen delivery. J Surg Res 2000; 92: 120-41.
15. Neuhof C, Wendling J, Dapper F et al. Endotoxemia and cytokine generation in cardiac surgery in relation to flow mode and duration of cardiopulmonary bypass. Shock 2001; 16: 39-43.
16. Gutierrez G. Metabolic assessment of tissue oxygenation. Sem Resp Crit Care Med 1999; 20: 11-15.
17. 2+ pump is defective during sepsis. Circ Shock 1994; 44: 121-25.
18. John LC, Rees GM, Kovacs IB. Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage. J Thorac Cardiovasc Surg 1993; 105: 816-22.
19. Ramsey G. The pathophysiology and organ-specific consequences of severe transfusion reactions. New Horiz 1994; 2: 575-81.
20. Wildevuur CRH. Towards safer cardiopulmonary bypass. In Longmore DB ed. Towards safer cardiac surgery. Lancaster: International Medical Publishers, 1980: 293-312.
21. Kozek-Langenecker SA, Mohammad SF, Masaki T, Kamerath C, Cheung AK. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry. Anesth Analg 2000; 90: 808-12.
22. van Oeveren W, Kazatchkin MD, Descamps-Latscha B et al. Deleterious effects of cardiopulmonary bypass: a prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985; 89: 888-99.
23. de Haan J, Boonstra PW, Tabuchi N, van Oeveren W, Ebels T. Retransfusion of thoracic wound blood during heart surgery obscures biocompatibility of the extra-corporeal circuit. J Thorac Cardiovasc Surg 1996; 111: 272-75.
24. Walpoth BH, Eggensperger N, Hauser SP et al. Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery. Int J Artif Organs 1999; 22: 210-16.
25. van Oeveren W, Jansen NJG, Bidstrup BP et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 1987; 44: 640-45.
26. Wildevuur CR, Eijsman L, Roozendaal KJ, Harder MP, Chang M, van Oeveren W. Platelet preservation during cardiopulmonary bypass with aprotinin. Eur J Cardiothorac Surg 1989; 3: 533-37.
27. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987; 13: 89-95.
28. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 744-47.
29. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg 1997; 84: 920-35.
30. de Vroege R, Rutten PMMJ, Kalkman C et al. Biocompatibility of three different membrane oxygenators: effect on complement, neutrophil and monocyte activation. Perfusion 1997; 12: 369-75.
31. de Vroege R, Wagemakers M, te Velthuis H et al. Comparison of three commercially available hollow fiber oxygenators: gas transfer performance and biocompatibility. ASAIO J 2001; 47: 37-44.
32. Gu YJ, Boonstra PW, Graaff R, Rijnsburger AA, Mungroop HH, van Oeveren W. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators. Artif Organs 2000; 24: 43-48.
33. Jansen PGM, te Velthuis H, Huybregts MAJM et al. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995; 110: 829-34.
34. Moen O, Fosse E, Braten J et al. Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocytes and complement activation. Perfusion 1994; 9: 109-17.
35. Ashraf S, Butler J, Tian Y et al. Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps. Ann Thorac Surg 1998; 65: 480-84.
36. Gu Y, de Vries A, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996; 112: 494-500.
37. Elliot MJ. Ultrafiltration and modified ultrafiltration in pediatric open-heart operations. Ann Thorac Surg 1993; 556: 1518-22.
38. Grünenfelder J, Zünd G, Schoeberlein A et al. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. Eur J Cardiothorac Surg 2000; 17: 77-83.
39. Yndgaard S, Andersen LW, Andersen C, Petterson G, Baek L. The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14: 399-401.
40. Bellomo R, Ronco C. Continuous haemofiltration in the intensive care unit. Crit Care 2000; 4: 339-45.
41. Jansen NJ, van Oeveren W, van den Broek L et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 102: 515-25.
42. Chaney MA. Corticosteroids and cardiopulmonary bypass. Chest 2002; 121: 921-31.
43. Fitch JC, Rollins S, Matis L et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999; 100: 2499-506.
44. Hayashi Y, Sawa Y, Nishimura M et al. P-selectin monoclonal antibody may attenuate the whole body inflammatory response induced by cardiopulmonary bypass. ASAIO J 2000; 46: 334-37.
45. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 1198-204.
46. Gamoso MG, Phillips-Bute B, Landolfo KP, Newman MF, Stafford-Smith M. Off-pump versus on-pump coronary artery bypass surgery postoperative renal dysfunction. Anesth Analg 2000; 91: 1080-84.
47. Arom KV, Flavin TF, Emery RW, Kshettry VR, Janey PA, Petersen RJ. Safety and efficacy of off-pump coronary artery bypass grafting. Ann Thorac Surg 2000; 69: 704-10.
48. Khan NE, De Souza A, Mister R et al. A randomised comparison of Off-Pump and On-Pump multivessel coronary-artery bypass surgery. N Engl J Med 2004; 350: 21-28.
49. Fromes Y, Gaillard D, Ponzio O et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002; 22: 527-33.
50. Haisjackl M, Birnbaum J, Redlin M et al. Splanchnic oxygen transport and lactate metabolism during normothermic cardiopulmonary bypass in humans. Anesth Analg 1998; 86: 22-27.
51. Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliot DC. Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg 2003; 185: 485-91.
52. Kincaid EH, Miller PR, Meredith JW, Rahman N, Chang MC. Elevated arterial base deficit in trauma patients: a marker of impaired oxygen utilization. J Am Coll Surg 1998; 187: 384-92.
53. Ryckwaert F, Boccara G, Frappier JM, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med 2002; 30: 1495-98.
54. Wang F, Dupuis JY, Nathan H, Williams K. An analysis of the association between preoperative renal dysfunction and outcome in cardiac surgery. Chest 2003; 124: 1852-62.
55. Birdi I, Angelini GD, Bryan AJ. Biochemical markers of myocardial injury during cardiac operations. Ann Thorac Surg 1997; 63: 879-84.
56. Panteghini M. Acute coronary syndrome: biochemical strategies in the troponin era. Chest 2002; 122: 1428-35.
57. Nesher N, Zisman E, Wolf T et al. Strict thermoregulation attenuates myocardial injury during coronary artery bypass graft surgery as reflected by reduced levels of cardiac-specific troponin I. Anesth Analg 2003; 96: 328-35.
58. Eigel P, van Ingen G, Wagenpfeil S. Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery. Eur J Cardiothorac Surg 2001; 20: 544-49.
59. Suzuki K, Sawa Y, Kagisaki K et al. Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70. Basic Res Cardiol 2000; 95: 397-403.
60. Bidmon B, Endemann M, Muller T, Arbeiter K, Herkner K, Aufricht C. Heat shock protein-70 repairs proximal tubule structure after renal ischemia. Kidney Int 2000; 58: 2400-407.
61. Chello M, Mastroroberto P, Patti G, Dámbrosio A, Di Sciascio G, Covino E. Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning. Cardiovasc Surg 2003; 11: 367-74.
62. Sam F, Colucci WS. Role of endothelin-1 in myocardial failure. Proc Assoc Am Physicians 1999; 111: 417-22.
63. te Veldhuis H, Jansen PGM, Oudemans van Straaten HM et al. Circulating endothelin in cardiac operations: influence on blood pressure and endotoxin. Ann Thorac Surg 1996; 61: 904-908.
64. Hornstein PS, Zaugg CE, Zhu P, Allegrini PR, Buser PT. Combined blockade of endothelin-1 and thromboxane A(2) receptors against postischaemic contractile dysfunction in rat hearts. Br J Pharmacol 2001; 132: 234-40.
65. Wagner FD, Buz S, Knosalla C, Hetzer R, Hocher B. Modulation of circulating endothelin-1 and big endothelin by nitric oxide inhalation following left ventricular assist device implantation. Circulation 2003; 108: II-278-84.
66. Hayashi Y, Sawa Y, Fukuyama N, Nakazawa H, Matsuda H. Preoperative glutamine administration induces heat-shock protein 70 expression and attenuates cardiopulmonary bypass-induced inflammatory response by regulating nitric oxide synthase activity. Circulation 2002; 106: 2601-607.
67. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E. S-100 protein in blood and urine during open heart surgery. Clin Chem 1989; 35: 1942-44.
68. Jönsson H, Johnsson P, Alling C, Bäckström M, Bergh C, Blomquist S. S100β after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg 1999; 68: 2202-208.
69. Missler U, Orlowski N, Nötzold A, Dibbelt L, Steinmeier E, Wiesman M. Early elevation of S-100Β protein in blood after cardiac surgery is not a predictor of ischemic cerebral injury. Clin Chim Acta 2002; 321: 29-33.
70. Westaby S, Saatvedt K, White S et al. Is there a relationship between serum S100beta protein and neuropsychologic dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2000; 119: 132-37.
71. Jorres A, Kordonouri O, Schiessler A et al. Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 1994; 18: 565-69.
72. Westhuyzen J, McGriffin DC, McCarthy J, Fleming SJ. Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 1994; 228: 123-32.
73. Lieberman J, Sacchettini J, Marks C, Marks WH. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 1997; 121: 335-42.
74. Lieberman JM, Marks WH, Cohn S et al. Organ failure, infection, and the systemic inflammatory response syndrome are associated with elevated levels of urinary intestinal fatty acid binding protein: study of 100 consecutive patients in a surgical intensive care unit. J Trauma 1998; 45: 900-906.
75. Holmes JH, Lieberman JM, Probert CB et al. Elevated intestinal fatty acid binding protein and gastrointestinal complications following cardiopulmonary bypass: a preliminary analysis. J Surg Res 2001; 100: 192-96.
76. Holcomb HB, Stammers AH, Gao C et al. Perfusion treatment algorithm: methods of improving the quality of perfusion. J Extra Corp Technol 2003; 35: 290-96.
77. Muller MM, Hackl W, Griesmacher A. Point-of-care-testing - the intensive care laboratory. Anaesthetist 1999; 48: 3-8.